TABLE 1.
Treatment condition | Concn (μg/ml) | No. of genes upregulated >3-folda |
---|---|---|
Control | 0 | |
Brilacidin | 0.39 | 171 |
0.78 | 415 | |
1.17 | 698 | |
Daptomycin | 2.0 | 258 |
4.0 | 293 | |
6.0 | 365 | |
LL16 | 2.0 | 276 |
4.0 | 436 | |
6.0 | 359 |
P < 0.05.
Treatment condition | Concn (μg/ml) | No. of genes upregulated >3-folda |
---|---|---|
Control | 0 | |
Brilacidin | 0.39 | 171 |
0.78 | 415 | |
1.17 | 698 | |
Daptomycin | 2.0 | 258 |
4.0 | 293 | |
6.0 | 365 | |
LL16 | 2.0 | 276 |
4.0 | 436 | |
6.0 | 359 |
P < 0.05.